Abstract
Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.
Author supplied keywords
Cite
CITATION STYLE
Luykx, J. J., Van Veen, S. M. P., Risselada, A., Naarding, P., Tijdink, J. K., & Vinkers, C. H. (2020, September 1). Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic. British Journal of Psychiatry. Cambridge University Press. https://doi.org/10.1192/bjp.2020.92
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
